Ignite Creation Date:
2025-12-25 @ 1:17 AM
Ignite Modification Date:
2026-02-04 @ 4:28 AM
Study NCT ID:
NCT05352893
Status:
COMPLETED
Last Update Posted:
2025-09-09
First Post:
2022-04-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPP
Sponsor:
Vanda Pharmaceuticals
Organization: